Alphinat News Free trial

Alphinat announces closing of a third and final tranche of its previously-announced private placement

THIS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MONTREAL (Quebec), February 11, 2011 – Alphinat Inc. (TSX Venture: NPA) a leader in innovative Software for the Smart Enterprise™, announces that it has completed the closing of the third and final tranche of its previously-announced private placement of units for a minimum gross proceeds of $500,000 and a maximum gross proceeds of $1,000,000 at a price of $0.10 per unit, each unit comprised of one common share and one eighth of a common share purchase warrant. Each whole warrant issued in connection with the third tranche entitles the holder to purchase one additional common share at a price of $0.12 on or before February 11, 2014. This final tranche brings the aggregate total up to the maximum intended financing of $1,000,000 under this private placement. The net proceeds from the private placement will be used to fund the expansion of the sales team and for working capital purposes. The units have been sold to “accredited investors” in the Province of Québec on a prospectus-exempt basis.

The closing of this third tranche results in the issuance of 1,000,000 units at a price of $0.10 for an aggregate gross proceeds to Alphinat of $100,000.

This third tranche closing follows the confirmation earlier this month by the TSX Venture Exchange of the suitability as insider of one of the subscribers.

In connection with the private placement, Alphinat has paid to Capital CCFL s.e.n.c., an Exempt Market Dealer registered with the Autorité des marchés financiers, a finder’s fee in a maximum amount equal to 6% of the gross proceeds of the private placement raised through CCFL Capital and grant compensation options to Capital CCFL to purchase up to 6% of the common shares issued in connection with the private placement. Each compensation option will entitle its holder to acquire one additional common share of Alphinat at a price of $0.10 on or before February 11, 2016.

The common shares and warrants issued by Alphinat under this third tranche closing are subject to a four-month hold period expiring on June 12, 2011, in accordance with applicable securities laws. The second closing of the private placement has increased the number of issued and outstanding common shares of Alphinat to 47,453,612. The private placement is subject to final regulatory approval from the TSX Venture Exchange.

About Alphinat

At Alphinat, we are driven by the passion to make application development easy for everyone. It always struck us as odd that the people with the vision of how a finished application should look and behave would only be involved at the start of the process. After all, what better way to ensure a favourable outcome than to provide those closest to an application’s end-users with a vested interest in its success throughout its development?

That’s why we bring you new ways to empower the right people at the right time in the application development process. At the same time, we’re constantly working to reduce the need to code in order to make application development and maintenance simpler and less error-prone.

So whether you choose to develop your applications with the help of our low-code platform SmartGuide®, kickstart your project using one of our pre-built apps or engage us or one of our partners to do the work for you, we’re here to help you deploy better applications in record time. Visit https://www.alphinat.com for more information. We look forward to hearing from you.

Forward-looking statements

Certain statements in this document, including those which express management's expectations or estimations with regard to the Company's future performance, constitute "forward-looking statements" as understood by applicable securities laws. Forward-looking statements are, of necessity, based on a certain number of estimates and hypotheses; while management considers these to be accurate at the time they are expressed, they are inherently subject to significant uncertainties and risks on the commercial, economic and competitive levels. We advise readers that these forward-looking statements are subject to risks, uncertainties, and other known and unknown factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied in these forward-looking statements. A number of factors could cause significant differences between actual results and those described in forward-looking statements. Investors are advised to not rely unduly on the forward-looking statements. This advisory applies to all forward-looking statements, whether expressed orally or in writing, attributed to Alphinat or to any individual expressing them in the name of the Company. Unless required by law, the Company is under no obligation to publicly update these forward-looking statements, whether to reflect new information, future events, or other circumstances. Risks and uncertainties that bear on the Company are described in greater detail in the Company's Annual Report.

READY FOR THE NEXT STEP?

Have a rep contact you.

+1 (312) 628-2394   |   +1 (514) 398-9799   |   +1 (617) 861-4685   |   +1 (646) 274-1189   |   +1 (877) 773-9799   |   Contact